KHIRON LIFE SCIENCES CORP (KHRN.CA) Stock Fundamental Analysis
Canada • TSX Venture Exchange • TSX-V:KHRN • CA49374L3065
0.04 CAD
0 (0%)
Last: May 5, 2023, 07:00 PM
We assign a fundamental rating of 2 out of 10 to KHRN. KHRN was compared to 34 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of KHRN have multiple concerns. KHRN is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
- In the past year KHRN has reported negative net income.
- In the past year KHRN has reported a negative cash flow from operations.
1.2 Ratios
- KHRN has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- KHRN's Gross Margin of 19.51% is in line compared to the rest of the industry. KHRN outperforms 47.73% of its industry peers.
- KHRN's Gross Margin has declined in the last couple of years.
- KHRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.81%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- KHRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for KHRN has been increased compared to 1 year ago.
- Compared to 1 year ago, KHRN has a worse debt to assets ratio.
2.2 Solvency
- KHRN has an Altman-Z score of -5.28. This is a bad value and indicates that KHRN is not financially healthy and even has some risk of bankruptcy.
- KHRN has a Altman-Z score of -5.28. This is in the lower half of the industry: KHRN underperforms 70.45% of its industry peers.
- A Debt/Equity ratio of 0.05 indicates that KHRN is not too dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.05, KHRN is doing good in the industry, outperforming 68.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.28 |
ROIC/WACCN/A
WACC6.71%
2.3 Liquidity
- A Current Ratio of 1.91 indicates that KHRN should not have too much problems paying its short term obligations.
- KHRN has a Current ratio (1.91) which is comparable to the rest of the industry.
- A Quick Ratio of 0.91 indicates that KHRN may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.91, KHRN is in line with its industry, outperforming 43.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
- KHRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.04%.
- The Revenue has grown by 38.20% in the past year. This is a very strong growth!
- Measured over the past years, KHRN shows a very strong growth in Revenue. The Revenue has been growing by 143.00% on average per year.
EPS 1Y (TTM)-59.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.56%
Revenue 1Y (TTM)38.2%
Revenue growth 3Y143%
Revenue growth 5YN/A
Sales Q2Q%-3.82%
3.2 Future
- Based on estimates for the next years, KHRN will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
- KHRN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.15% yearly.
EPS Next Y39.13%
EPS Next 2Y31.88%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year36.43%
Revenue Next 2Y38.09%
Revenue Next 3Y45.7%
Revenue Next 5Y40.15%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for KHRN. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KHRN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as KHRN's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.88%
EPS Next 3Y25.99%
5. Dividend
5.1 Amount
- No dividends for KHRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
KHIRON LIFE SCIENCES CORP / KHRN.CA FAQ
What is the ChartMill fundamental rating of KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to KHRN.CA.
Can you provide the valuation status for KHIRON LIFE SCIENCES CORP?
ChartMill assigns a valuation rating of 3 / 10 to KHIRON LIFE SCIENCES CORP (KHRN.CA). This can be considered as Overvalued.
Can you provide the profitability details for KHIRON LIFE SCIENCES CORP?
KHIRON LIFE SCIENCES CORP (KHRN.CA) has a profitability rating of 0 / 10.
What is the financial health of KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?
The financial health rating of KHIRON LIFE SCIENCES CORP (KHRN.CA) is 1 / 10.
What is the expected EPS growth for KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?
The Earnings per Share (EPS) of KHIRON LIFE SCIENCES CORP (KHRN.CA) is expected to grow by 39.13% in the next year.